INRLFValneva SE

About Valneva SE (INRLF)

Valneva SE (INRLF) is a Biotechnology company headquartered in Saint-Herblain, France whose shares trade over-the-counter on the Pink tier.

Intercell is an innovative biotechnology company focused on the design and development of novel vaccines for the prevention and treatment of infectious diseases. Intercell's products target markets with substantial unmet medical needs, and aim to improve health conditions for millions of people worldwide.

INRLF key facts

Ticker symbol

INRLF

Market tier

Pink

Sector

Healthcare

Industry

Biotechnology

Headquarters

Saint-Herblain, France

Country of incorporation

AT

Year of incorporation

1998

Employees

400

Estimated market cap

$543.63M (as of May 12, 2025)

Shares outstanding

167,271,524

Reporting standard

International Reporting: Euronext Paris

Audit status

Audited

Fiscal year end

12/31

Latest filing

Annual Report (Dec 31, 2012)

Valneva SE leadership

• Thomas Szucs — Chairman of the Supervisory Board
• Thomas Lingelbach — CEO
• Ernst-Gunter Afting — Bankruptcy Plan Admin.
• Reinhard Kandera — CFO

Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with I